Type of study/ Design: Randomized, double-blind, placebo-controlled clinical trial.~Sponsor: Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol / Hospital Universitari Germans Trias i Pujol ( IGTP / HUGTIP)~Title of the clinical trial: Efficacy of micronutrient dietary supplementation in reducing hospital admissions for COVID-19: A double-blind, placebo-controlled, randomized clinical trial.~Protocol code: CoVIT Clinical Trial~NºClinicaltrials.gov: Pending~Coordinating researcher: Dra. Teresa-Maria Tomasa-Irriguible.~Recruiting Center: Germans Trias i Pujol University Hospital (HUGTIP)~Ethical Committee for clinical Investigation (CEI): Germans Trias i Pujol University Hospital CEI.~Monitoring: Clinical Research Associate at UPIC (Unitat Polivalent d'Investigació Clínica) Clinical Trial Unit- IGTP~Study treatments: Dietary supplement with micronutrients and Placebo~Test phase: Not applicable.~Main objective: Evaluation of the effectiveness of supplementation with a dietary supplement to improve the need for hospital admission for SARS-CoV-2 infection.~Study pathology: COVID-19.~Main variable: The need for hospital admission of SARS-CoV-2 documented infection~Study population and total number of patients: Patients of the health system of the Northern Metropolitan Area of Catalan Health Institution with symptoms compatible with SARS-CoV-2 infection. A total of 300 people (150 treated with dietary supplement and 150 with placebo).~Duration of treatment: 14 days.~Patients follow-up: 180 days
A double-blind, placebo-controlled, randomized clinical trial to assess efficacy of micronutrient dietary supplementation in reducing hospital admissions for COVID-19.~We want to assess the need for hospital admission for severe acute respiratory syndrome Corona Virus-2 (SARS-CoV-2) infection in outpatients diagnosed of COVID-19 disease, taking a micronutrient supplementation for 14 days. The outcome Will be measured within 1 month after beginning the study treatment. The patients will be followed-up for a period of 180 days.